Aromatase inhibition to enhance assisted reproduction
US7846957B2 · kind B2 · utility
0Cited by
6References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2002 |
| Grant date | Dec 7, 2010 |
| Priority date | — |
| Expiry date | Oct 12, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of at least one aromatase inhibitor in the production of a medicament for improving the implantation and pregnancy rates for a female undergoing assisted reproduction treatment, which comprises one or more daily doses of an aromatase inhibitor (AI) for administration during assisted reproduction cycles or ovarian stimulation cycles, wherein the doses of AI are selected from amounts effective to reduce serum estradiol levels. Also disclosed are related pharmaceutical preparations and packages.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.